Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Overweight on Duckhorn Portfolio, Raises Price Target to $13

Author: Benzinga Newsdesk | December 08, 2023 07:05am
Barclays analyst Lauren Lieberman maintains Duckhorn Portfolio (NYSE:NAPA) with a Overweight and raises the price target from $12 to $13.

Posted In: NAPA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist